Journal profile · Instruments & Instrumentation
mAbs
ISSN 1942-0862 · eISSN 1942-0870 · Landes Bioscience · UNITED STATES · Bimonthly · Founded 2009
mAbs: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 7.85; JCR Q1 (journal website); fully open access; APC about USD 4,390; median 87 days to acceptance (94 articles, last 24 months); acceptance rate 34% (journal website); 132 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
mAbs is published by Landes Bioscience and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and Glycosylation and Glycoproteins Research, together about 57.5% of its articles. Its main subfields are Immunology and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
mAbs is a multidisciplinary, open access journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus but serves a broad readership, including specialists in patents, business development, portfolio planning, and the regulation of biotherapeutics. mAbs covers a range of topics, including: Engineering and selection of antibody therapeutics, including antibody-drug conjugates, multispecific antibodies, and single-domain antibodies Machine learning and artificial intelligence applications Non-clinical studies of antibodies, such as mechanism of action studies, safety and efficacy studies in animals Manufacturing and formulation The article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary, Meeting Report, Editorial, and Letter to the Editor. NOTE: We reject manuscripts that describe antibody production using the ascites method. The method is now hardly ever used, as it is broadly considered cruel to the animals involved, but it is worth stating this explicitly to prospective authors. If a manuscript describes crystal structure(s), the manuscript should include a Protein Data Bank (PDB) number that allows readers to view the data. The journal operates a single-anonymized peer review policy.
From the journal's Aims & Scope
Research area (LetPub): Instruments & Instrumentation
Editor-in-chief Janice M. ReichertPublisher website
Editorial board by country: none in mainland China; most named United States 4 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Monoclonal and Polyclonal Antibodies ResearchMedicine32.8%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology14.9%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology9.8%
- Viral Infectious Diseases and Gene Expression in InsectsBiochemistry, Genetics and Molecular Biology6.1%
- CAR-T cell therapy researchMedicine4.9%
- Biosimilars and Bioanalytical MethodsImmunology and Microbiology4.8%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.3%
- HER2/EGFR in Cancer ResearchMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbasePublisher website
Other: EBSCOhost - Biological Abstracts (Online)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.85LetPub ·
- Impact factor (publisher) 2025
- 7.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 6.2Publisher website ·
- CiteScore 2026-06
- 11.9LetPub ·
- CiteScore (publisher) 2025
- 11.9Publisher website ·
- SJR 2026-06
- 2.07LetPub ·
- SJR (publisher) 2025
- 2.07Publisher website ·
- SNIP 2026-06
- 1.61LetPub ·
- SNIP (publisher) 2025
- 1.61Publisher website ·
- h-index
- 65LetPub ·
- h-index
- 129OpenAlex ·
- i10-index
- 1,412OpenAlex ·
- 2-year mean citedness
- 8.36OpenAlex ·
- Self-citation rate
- 12.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 124LetPub ·
- Downloads per year (publisher)
- 1,900,000Publisher website ·
Articles by year OpenAlex count · 1,910 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 89 | 89 | 117 |
| 2025 | 132 | 132 | 931 |
| 2024 | 99 | 99 | 1,628 |
| 2023 | 95 | 95 | 2,854 |
| 2022 | 89 | 89 | 2,906 |
| 2021 | 105 | 105 | 3,639 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
87 daysMedian, submission to acceptance · P25–P75 62 days – 113 days
- Acceptance to online
- median 10 days (94 articles)
- Submission to online
- median 98 days
- Sample
- 94 articles with submission and acceptance dates (249 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Acceptance rate (publisher)
- 34%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 28 daysPublisher website ·
- Acceptance to publication
- 12 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | AUD 6,110 / EUR 4,215 / GBP 3,510 / USD 4,390 | Yes | CC BY, CC BY-NC | |
| OpenAlex | GBP 2,915 | — | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted12
- article commentaryThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- data notesThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- discussionThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- editorialThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- letter to the editorThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- meeting reportThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- methodsThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- rapid communicationThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- reportThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- researchThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- reviewThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
- software toolsThe article types published in mAbs include: Research, Rapid Communication, Data Notes, Software Tools, Methods, Report, Review, Discussion, Article Commentary,…Length not stated
Policy excerpts from the journal's websiteData availability, Publication ethics, Open access, Peer review
- Data availability
Manuscripts describing crystal structures must include a Protein Data Bank (PDB) number Model summary
If a manuscript describes crystal structure(s), the manuscript should include a Protein Data Bank (PDB) number that allows readers to view the data.
Source ↗Publisher website ·- Publication ethics
Rejects manuscripts describing antibody production using the ascites method Model summary
NOTE: We reject manuscripts that describe antibody production using the ascites method.
Source ↗Publisher website ·- Open access Open access
mAbs is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not just those with easy access t…
Source ↗Publisher website ·- Peer review
Single-anonymized peer review Model summary
The journal operates a single-anonymized peer review policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Landes Bioscience
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2009
- ISSN
- 1942-0862
- Electronic ISSN
- 1942-0870
- Latest issue on the website
- Volume 18, Issue 1 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about mAbs
What CAS zone is mAbs in?
In the 2025 upgraded edition of the CAS Journal Ranking, mAbs is in Zone 2 of Medicine, and in Zone 2 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of mAbs?
The latest impact factor listed by LetPub is 7.85; CiteScore 11.9, h-index 129.
How long does peer review take at mAbs?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 62–113 days); authors report an average review time of 6–12 weeks; the journal's website gives an acceptance rate of 34%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is mAbs in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Where are the editorial board members of mAbs based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (4). Counted from the institutions listed on the board page; for reference only.
Which databases index mAbs?
According to LetPub and DOAJ records, mAbs is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PubMed and Embase; that list has not been checked against each database.
Is mAbs open access, and what is the APC?
mAbs is a fully open-access journal. APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .